HC Wainwright & Co. reiterated coverage on Capricor Therapeutics with a new price target

1/31/22 9:27:57 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Capricor Therapeutics with a rating of Buy and set a new price target of $18.00 from $14.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CAPR

Date	Price Target	Rating	Analyst
5/20/2025	$31.00	Buy	Roth Capital
10/21/2024	$35.00	Overweight	Piper Sandler
5/17/2024	$14.00	Outperform	Oppenheimer
1/5/2024	$8.00	Overweight	Cantor Fitzgerald
10/26/2022	$15.00	Buy	Ladenburg Thalmann
1/31/2022	$14.00 → $18.00	Buy	HC Wainwright & Co.
10/11/2021	$9.00 → $14.00	Buy	HC Wainwright & Co.